HRS-1780 tablets

DRUG3 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd.

Conditions

Chronic Kidney DiseasePrimary AldosteronismType 2 Diabetes Mellitus

Phase 1

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

Not yet recruitingNCT06495931

Shandong Suncadia Medicine Co., Ltd.Type 2 Diabetes Mellitus

Start: 2024-07-31End: 2024-07-31Target: 24Updated: 2024-07-11

Phase 2

A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism

Not yet recruitingNCT07470983

Shandong Suncadia Medicine Co., Ltd.Primary Aldosteronism

Start: 2026-03-01End: 2026-11-01Target: 60Updated: 2026-04-01

Phase 3

A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease

RecruitingNCT07419828

Shandong Suncadia Medicine Co., Ltd.Chronic Kidney Disease

Start: 2026-03-13End: 2030-05-01Target: 1978Updated: 2026-03-27